Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double-blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose With Placebo in Patients With Anaemia Undergoing Major Open Abdominal Surgery

NCT01692418 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT01692418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01692418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double-blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose With Placebo in Patients With Anaemia Undergoing Major Open Abdominal Surgery
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
May 31, 2019
Enrollment
487 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia